1,2-distearoylphosphatidylethanolamine has been researched along with Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Wang, P; Wang, Y; Xia, X; Yan, D | 1 |
| Belhadj, Z; Dai, W; Fu, J; He, B; Wang, X; Zhang, H; Zhang, Q | 1 |
| Ahlgren, S; Edwards, K; Reijmar, K | 1 |
| Chen, S; Cheng, Z; He, S; Li, D; Liu, J; Liu, L; Qu, J; Song, J; Wu, Y; Zhang, X | 1 |
| Arai, M; Harada, A; Kono, K; Kono, Y; Kubo, K; Yokoyama, S; Yuba, E | 1 |
| Cai, X; Gong, W; Mei, X; Wang, Z; Xie, X; Yang, Y; Zhang, H | 1 |
| Fahr, A; Hilger, I; Kontermann, RE; Rabenhold, M; Rüger, R; Steiniger, F; Tansi, FL | 1 |
| Ara, MN; Harashima, H; Hida, K; Hyodo, M; Matsuda, T; Ohga, N; Sakurai, Y | 1 |
| Amitay, Y; Gabizon, A; Ohana, P; Patil, Y; Shmeeda, H | 1 |
| Hu, J; Ju, H; Liu, F | 1 |
| Kadowaki, N; Kodama, T; Maruyama, K; Namai, E; Oda, Y; Okada, N; Suzuki, R; Tachibana, K; Taira, Y; Utoguchi, N | 1 |
| Beuttler, J; Frejd, FY; Kontermann, RE; Müller, D; Rothdiener, M | 1 |
| Benoît, JP; Brodin, P; Carmoy, N; Legras, P; Montier, T; Morille, M; Passirani, C; Pitard, B | 1 |
| Antony, AC; Guo, L; Jayaram, HN; Roeske, RW; Zhang, Y | 1 |
| Hashida, M; Kawakami, S; Mizobata, M; Terada, T; Yamashita, F | 1 |
| Bally, MB; Chiu, GN; Mayer, LD | 1 |
16 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Neoplasms
| Article | Year |
|---|---|
Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Mice; Micelles; Nanoparticles; Neoplasms; Oxidation-Reduction; Paclitaxel | 2023 |
Regulating Interactions Between Targeted Nanocarriers and Mononuclear Phagocyte System via an Esomeprazole-Based Preconditioning Strategy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Biological Transport; Cell Death; Cell Survival; Doxorubicin; Drug Carriers; Endocytosis; Esomeprazole; Humans; Lysosomes; MCF-7 Cells; Mice; Mice, Nude; Mononuclear Phagocyte System; Nanoparticles; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; RAW 264.7 Cells; Tissue Distribution; Vacuolar Proton-Translocating ATPases | 2020 |
Targeting lipodisks enable selective delivery of anticancer peptides to tumor cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Melitten; Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols | 2017 |
High Affinity to Skeleton Rare Earth Doped Nanoparticles for Near-Infrared II Imaging.
Topics: Blood Vessels; Bone and Bones; Cell Line, Tumor; Fluorescent Dyes; Humans; Lymph Nodes; Metals, Rare Earth; Nanoparticles; Neoplasms; Optical Imaging; Phosphatidylethanolamines; Skeleton; Thrombosis | 2019 |
The application of pH-sensitive polymer-lipids to antigen delivery for cancer immunotherapy.
Topics: Animals; Antigens; Arylsulfonates; Cell Line; Female; Hydrogen-Ion Concentration; Immunity; Immunization; Immunotherapy; Lipids; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Phosphatidylethanolamines; Phycoerythrin; Polymers; Rhodamines; Temperature | 2013 |
PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Doxorubicin; Endocytosis; Female; Flow Cytometry; Humans; Ligands; Mice; Mice, Nude; Neoplasms; Oligopeptides; Phosphatidylethanolamines; Polyethylene Glycols; Temperature | 2014 |
In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Cells, Cultured; Endopeptidases; Female; Fluorescent Dyes; Gelatinases; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Liposomes; Maleimides; Membrane Proteins; Mice, Nude; Neoplasms; Optical Imaging; Phosphatidylethanolamines; Polyethylene Glycols; Serine Endopeptidases; Single-Chain Antibodies; Spectroscopy, Near-Infrared | 2014 |
Construction of an aptamer modified liposomal system targeted to tumor endothelial cells.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; HSP70 Heat-Shock Proteins; Humans; Liposomes; Lysosomes; Maleimides; Mice; Mice, Nude; Nanoparticles; Neoplasms; NIH 3T3 Cells; Phosphatidylethanolamines; Polyethylene Glycols; Proteomics; Skin | 2014 |
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cholesterol; Female; Folic Acid; Folic Acid Transporters; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Molecular Targeted Therapy; Neoplasms; Peritoneal Diseases; Phosphatidylethanolamines; Polyethylene Glycols; Prodrugs | 2016 |
MALDI-MS Patterning of Caspase Activities and Its Application in the Assessment of Drug Resistance.
Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Neoplasms; Peptides; Phosphatidylethanolamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Tin Compounds | 2016 |
A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
Topics: Animals; Antigen Presentation; Antigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cytotoxicity Tests, Immunologic; Dendritic Cells; Endocytosis; Fluorocarbons; Immunotherapy, Active; Interleukin-2; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sodium Azide; Survival Analysis; T-Lymphocytes, Cytotoxic; Ultrasonics | 2009 |
Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).
Topics: Antibodies; Biological Transport; Cell Line, Tumor; Cysteine; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Liposomes; Maleimides; Mitoxantrone; Nanostructures; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Recombinant Fusion Proteins; Substrate Specificity | 2009 |
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Topics: Animals; Cell Death; Cell Line; Complement System Proteins; DNA; Gene Transfer Techniques; Genetic Vectors; Humans; Injections, Intravenous; Kinetics; Lipids; Macrophages; Mice; Mice, Nude; Microscopy, Fluorescence; Nanocapsules; Neoplasms; Particle Size; Phosphatidylethanolamines; Surface Properties; Time Factors; Tissue Distribution | 2010 |
Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Topics: Caco-2 Cells; Carrier Proteins; Chromatography, High Pressure Liquid; Cysteine; Doxorubicin; Fluoresceins; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Liposomes; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Receptors, Cell Surface | 2004 |
Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cricetulus; Erythrocytes; Fibroblast Growth Factor 2; Fibroblasts; Humans; Liposomes; Macrophages; Mice; Microscopy, Confocal; Neoplasms; Oligopeptides; Phosphatidylethanolamines; Polyethylene Glycols; Protein Binding; Receptor, Fibroblast Growth Factor, Type 1; Recombinant Proteins | 2007 |
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
Topics: Animals; Cell Membrane; Drug Delivery Systems; Lipoproteins; Liposomes; Mice; Micelles; Neoplasms; Phosphatidylethanolamines; Phosphatidylserines; Polyethylene Glycols; Surface Properties; Time Factors | 2002 |